[18F] MFBG PET imaging: biodistribution, pharmacokinetics, and comparison with [123I] MIBG in neural crest tumour patientsElin Pauwels, Christophe M. Deroose, Koen Van Laere et al.|European Journal of Nuclear Medicine and Molecular Imaging|2022Cited by 23
[<sup>68</sup>Ga]Ga-DOTATATE-avid tumor volume, uptake and inflammation-based index correlate with survival in neuroendocrine tumor patients treated with [<sup>177</sup>Lu]Lu-DOTATATE PRRT.Elin Pauwels, Christophe M. Deroose, Jeroen Dekervel et al.|PubMed|2022Cited by 11
Influence of pretreatment with everolimus or sunitinib on the subacute hematotoxicity of <sup>177</sup>Lu-DOTATATE PRRTEva Medaer, Christophe M. Deroose, Chris Verslype et al.|Acta Oncologica|2020Cited by 10
Influence of pretreatment with everolimus or sunitinib on the subacute hematotoxicity of <sup>177</sup>Lu-DOTATATE PRRTEva Medaer, Christophe M. Deroose, Chris Verslype et al.|Figshare|2021Cited by 0
Evaluation of [¹⁸F]AlF-NOTA-octreotide PET/CT in routine clinical use: a retrospective analysis in 288 neuroendocrine tumor patientsHannes Leupe, Christophe M. Deroose, Sophie-Anne De Buyst et al.|European Journal of Nuclear Medicine and Molecular Imaging|2026Cited by 0